RAPT Therapeutics Inc
RAPT
Mkt cap
$132.08M
EV/Sales
N/A
P/E ratio
N/A
FY2023 Revenue
N/A
EPS (9mo ended 2025-09-30)
$-1.94
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
N/A
Beta
-0.14
Div yield
N/A
Sector
Healthcare
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Use this RAPT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RAPT income, balance, and cash tables.
RAPT Therapeutics Inc (RAPT) is a biotechnology company in the Healthcare sector.
Latest cached RAPT Therapeutics Inc (RAPT) net income for Dec 31, 2023 was -$116.8M. Statements: https://lician.com/financials/rapt
RAPT Therapeutics Inc (RAPT) market capitalization is $132.1M on the latest cached snapshot.
The latest cached RAPT filing is 8-K · Jan 14, 2026. Filings: https://lician.com/sec/rapt